chr16-28911149-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_024816.3(RABEP2):c.925G>A(p.Val309Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000397 in 1,611,966 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V309L) has been classified as Uncertain significance.
Frequency
Consequence
NM_024816.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RABEP2 | NM_024816.3 | c.925G>A | p.Val309Ile | missense_variant | 6/13 | ENST00000358201.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RABEP2 | ENST00000358201.9 | c.925G>A | p.Val309Ile | missense_variant | 6/13 | 1 | NM_024816.3 | P1 | |
RABEP2 | ENST00000357573.10 | c.895-163G>A | intron_variant | 1 | |||||
RABEP2 | ENST00000562590.5 | n.1446G>A | non_coding_transcript_exon_variant | 6/7 | 1 | ||||
RABEP2 | ENST00000544477.5 | c.712G>A | p.Val238Ile | missense_variant | 5/12 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152218Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000202 AC: 5AN: 247554Hom.: 0 AF XY: 0.0000372 AC XY: 5AN XY: 134576
GnomAD4 exome AF: 0.0000411 AC: 60AN: 1459748Hom.: 0 Cov.: 32 AF XY: 0.0000523 AC XY: 38AN XY: 726288
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74356
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at